Effect of Cemented Implantation in Shoulder Replacement on Blood Pressure
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03364062 |
|
Recruitment Status : Unknown
Verified November 2017 by Zhang Peixun, Peking University People's Hospital.
Recruitment status was: Not yet recruiting
First Posted : December 6, 2017
Last Update Posted : December 6, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Blood Pressure | Procedure: cemented shoulder replacement |
| Study Type : | Observational |
| Estimated Enrollment : | 350 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | A Multi-center Study on Effect of Cemented Implantation in Shoulder Replacement on Blood Pressure |
| Estimated Study Start Date : | February 10, 2018 |
| Estimated Primary Completion Date : | December 10, 2019 |
| Estimated Study Completion Date : | December 10, 2019 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
cemented shoulder replacement patients
A total of 350 cases of proximal humeral fracture receiving cemented shoulder replacement in Department of Orthopedics and Trauma
|
Procedure: cemented shoulder replacement
proximal humeral fracture receiving hemi-shoulder replacement with cement when inserting the stem |
- Change from Baseline Systolic Blood Pressure [ Time Frame: Change from Baseline Systolic Blood Pressure at 15 mins ]the systolic blood pressure after insert the cemented stem
- Change from Baseline Diastolic Blood Pressure [ Time Frame: Change from Baseline Diastolic Blood Pressure at 15 mins ]the diastolic blood pressure after insert the cemented stem
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 85 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
•patients with three or four part of proximal humeral fracture receiving cemented shoulder replacement
Exclusion Criteria:
- pathologic fracture
- severe hypertension or hypotension
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03364062
| Contact: Yichong Zhang, MD | 15210802766 | 875274428@qq.com |
| Principal Investigator: | Yichong Zhang, MD | Peking University People's Hospital |
| Responsible Party: | Zhang Peixun, Clinical Professor, Peking University People's Hospital |
| ClinicalTrials.gov Identifier: | NCT03364062 |
| Other Study ID Numbers: |
GCS-CISR |
| First Posted: | December 6, 2017 Key Record Dates |
| Last Update Posted: | December 6, 2017 |
| Last Verified: | November 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Blood Pressure shoulder replacement proximal humeral fracture |

